Ardan Equity

Ardan Equity is a private equity firm based in Palm Beach, Florida, established in 2018. It specializes exclusively in the healthcare and life sciences software and data sector. The firm collaborates closely with founders and management teams to accelerate growth and develop leading platforms in the market. Ardan's focus is on creating differentiated solutions across various healthcare segments, including life sciences, payers, providers, and employers. By leveraging proprietary growth strategies, a trusted network, and experienced executives, Ardan aims to deliver superior risk-adjusted performance while fostering innovation in healthcare software.

Drew Boston

Founding Partner

Noah Lewis

Co-Founder, Managing Partner and Healthcare Software Investments

5 past transactions

MMIT

Private Equity Round in 2021
Formularies from P&T to point of care: MMIT brings transparency and guidance to pharmacy and medical benefit information. Payers, pharmaceutical companies, providers and pharmacies use our data and workflow app to provide clarity from P&T to the point of care, ensuring consistent managed care decisions across the healthcare market.

WellSky

Private Equity Round in 2020
WellSky is a provider of comprehensive software solutions and professional services designed for the healthcare and social services sectors. With over 25 years of experience, the company focuses on addressing the continuum of care by offering tools that facilitate collaboration among organizations and communities. WellSky's software supports a range of healthcare environments, including acute and non-acute care, and is used by healthcare providers, accountable care organizations, and government entities worldwide. The company's offerings aim to improve performance management, cost control, and quality of care, while also delivering predictive insights to help organizations navigate the complexities of their industries.

HealthEdge

Private Equity Round in 2020
HealthEdge provides modern, disruptive technology that delivers for the first time, a suite of products that enables healthcare payors to leverage new business models, improve outcomes, drastically reduce administrative costs, and connect everyone in the healthcare delivery cycle. Their next-generation enterprise product suite, HealthRules, is built on modern, patented technology and is delivered to customers via the HealthEdge Cloud or on-site deployment. They enable their customers to radically innovate, drastically reduce costs, and efficiently address the business imperatives of the evolving healthcare economy. HealthEdge was founded by Albert Waxman of Psilos Group and Rob Gillette in December 2004. In January 2005, the company acquired over $125 million in intellectual property and other assets. This technology served as the foundation for the patented, award-winning HealthRules product suite. In December 2012, HealthEdge acquired Click4Care, a care management, and utilization management software company, adding next-generation clinical capabilities to the award-winning HealthRules product suite. HealthEdge is headquartered in Burlington, Massachusetts, and maintains an R&D center in Powell, Ohio.

CorEvitas

Private Equity Round in 2019
CorEvitas is a provider of clinical registry data and analytics services focused on the biopharmaceutical sector. Established in 2000 and headquartered in Waltham, Massachusetts, the company specializes in delivering real-world evidence through its extensive registry data, which includes insights on patient experiences and outcomes. CorEvitas operates six autoimmune registries across the United States, Canada, and Japan, collecting data from over 400 participating investigator sites. The company ensures the accuracy and completeness of its data through rigorous quality control processes before it is stored in a secure data warehouse. Additionally, CorEvitas conducts active safety surveillance to support regulatory commitments for new drug approvals, contributing to post-authorization safety studies. The company's mission is to advance patient care and improve treatment through comprehensive real-world data analysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.